Loading...
XSTO
BRAIN
Market cap13mUSD
Jul 09, Last price  
0.81SEK
1D
-0.61%
1Q
26.56%
Jan 2017
-90.25%
IPO
-72.73%
Name

BrainCool AB (publ)

Chart & Performance

D1W1MN
XSTO:BRAIN chart
P/E
P/S
3.59
EPS
Div Yield, %
Shrs. gr., 5y
25.31%
Rev. gr., 5y
38.79%
Revenues
36m
-9.38%
779,733998,7871,287,2434,256,0517,032,0619,264,34217,588,40723,227,00439,961,00036,214,000
Net income
-37m
L-15.88%
-13,482,278-23,081,547-38,939,469-57,282,019-37,304,149-38,750,101-45,612,929-61,275,951-44,042,000-37,050,000
CFO
-53m
L-15.90%
-15,185,017-29,142,023-25,280,277-56,011,266-39,249,729-24,247,129-46,268,680-61,160,433-62,636,000-52,677,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BrainCool AB (publ), a medical technology company founded in 2010 and headquartered in Lund, Sweden, focuses on the development, commercialization, and distribution of advanced medical cooling systems. Operating with its subsidiaries, the company caters to the healthcare sector, primarily serving the Swedish market, by providing innovative solutions for various conditions including stroke, sudden cardiac arrest, oral mucositis, and migraine. Their product line features the BrainCool and RhinoChill systems, specifically engineered to deliver swift therapeutic cooling in emergency situations, thereby ensuring uninterrupted patient care. To mitigate the risk of oral mucositis, BrainCool offers the Cooral system, renowned for its user-friendly design for medical professionals. Furthermore, the IQool system boasts an intuitive interface complemented by informative graphics and an automatic feedback loop, empowering clinicians to dedicate their attention to patient management rather than device operation.
IPO date
May 07, 2014
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT